Genome is a Berlin-based fintech that turns fragmented financial data into actionable intelligence for wealth managers and family offices. Rather than forcing advisors to manually piece together client portfolios across multiple custodians and platforms, Genome aggregates real-time data and delivers a unified view—think of it as the operating system for complex wealth. The platform handles everything from portfolio monitoring and risk analysis to reporting and compliance, automating the grunt work that still consumes hours of advisor time each week.
What sets Genome apart is its focus on the enterprise wealth management market, where institutional-grade infrastructure matters more than flashy consumer features. It works directly with private banks, wealth managers, and fintech platforms that need bulletproof data integration and regulatory compliance built in from day one. Most competitors in this space either build for consumers or offer clunky, legacy-style solutions; Genome approaches it like a modern API-first infrastructure layer.
In the European context, where wealth management remains fragmented across countries and custody models, Genome's cross-border capabilities and multi-asset support address a real pain point. It's positioned as the connective tissue between traditional private banking and a new generation of digital-first advisors—not replacing advisors, but giving them the tools to scale and focus on actual strategy instead of data management.